A Metabolomics Profiling Study in Hand-Foot-and-Mouth Disease and Modulated Pathways of Clinical Intervention Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry
PLS-DA score plots based on the data from the healthy controls and the HFMD patients. (a) PLS-DA score plots under positive ESI ion mode. (b) PLS-DA score plots under negative ESI ion mode. The black square: healthy control group; the red circle: HFMD group; the blue diamond: combination therapy group.